FAM104B: A Potential Drug Target and Biomarker for the Treatment of Human Cancer

Target Name: FAM104B

NCBI ID: G90736

FAM104B

FAM104B: A Potential Drug Target and Biomarker for the Treatment of Human Cancer

Abstract:
FAM104B (FAM104B variant 2) is a gene that encodes for a protein known as FAM104B, which plays a crucial role in various cellular processes, including cell adhesion, migration, and invasion. Despite its importance, FAM104B has not yet been thoroughly studied, and its potential drug target and biomarker properties are not yet fully understood. In this article, we will explore the potential drug target and biomarker properties of FAM104B, and discuss its potential clinical applications in the treatment of human cancer.

Introduction:
FAM104B is a gene that encodes for a protein known as FAM104B, which is a key regulator of various cellular processes, including cell adhesion, migration, and invasion. FAM104B has been shown to play a crucial role in the development and progression of various types of cancer, including breast, ovarian, and colorectal cancer.

Despite its importance, FAM104B has not yet been thoroughly studied, and its potential drug target and biomarker properties are not yet fully understood. In the following sections, we will explore the potential drug target and biomarker properties of FAM104B, and discuss its potential clinical applications in the treatment of human cancer.

Potential Drug Target:
FAM104B has been shown to play a crucial role in the development and progression of various types of cancer, including breast, ovarian, and colorectal cancer. It has been shown to promote the growth and survival of cancer cells, and to contribute to their migration and invasion.

The potential drug target for FAM104B is its role in cell adhesion and migration. Cancer cells need to adhere to the surrounding tissue to maintain their structure and to support their growth, and they also need to migrate to new sites to promote their growth and progression. FAM104B plays a crucial role in these processes, as it is involved in the regulation of cell-cell adhesion and in the migration of cells.

FAM104B has been shown to promote the formation of tight junctions, which are essential for the regulation of cell-cell adhesion. tight junctions are specialized junctions that form between cells, and they play a crucial role in maintaining the integrity of the cell membrane and the regulation of ion and solute transport.

FAM104B has also been shown to promote the migration of cells. Migration is a critical process for cancer cells, as it allows them to escape the immune system and to establish new tumors in other parts of the body. FAM104B plays a crucial role in this process, as it is involved in the regulation of cell-cell adhesion and in the migration of cells.

Potential Biomarker:
FAM104B has the potential to serve as a biomarker for the diagnosis and prognosis of various types of cancer. Its involvement in cell adhesion and migration makes it an attractive candidate for use as a biomarker for cancer diagnosis and treatment.

FAM104B has been shown to have potential clinical applications in the treatment of breast, ovarian, and colorectal cancer. By inhibiting the role of FAM104B in cell adhesion and migration, researchers may be able to develop new treatments for these cancers.

Conclusion:
In conclusion, FAM104B is a gene that encodes for a protein that plays a crucial role in various cellular processes, including cell adhesion, migration, and invasion. Despite its importance, FAM104B has not yet been thoroughly studied, and its potential drug target and biomarker properties are not yet fully understood. Further research is needed to fully explore the potential of FAM104B as a drug target and biomarker

Protein Name: Family With Sequence Similarity 104 Member B

The "FAM104B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM104B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets